Treatment Archives – Page 3 of 11 – Treatment Action Group

Open Letter: Urgent Action Necessary for Equitable Access to Bedaquiline in All Countries with High Burdens of TB, MDR-TB, and TB/HIV

July 11, 2023
Dorrit Walsh

TAG and 82 other organizations and 106 individuals representing TB-affected communities and civil society sent an open letter to Johnson & Johnson calling on the company...

The ABC for a TB Activist: 1/4/6×24 Campaign and Supportive Diagnostics

June 16, 2023
Dorrit Walsh

On 15 June, 2023, TB Europe Coalition (TBEC) organized a webinar featuring a presentation by Treatment Action Group’s TB Project Officer, David Branigan, on the practical actions advocates can take to promote the adoption and scale up of shorter, safer 1/4/6 regimens for TB prevention and the treatment of drug-sensitive and drug-resistant TB as well as supportive diagnostics.

SMART4TB CONSORTIUM ANNOUNCES COMMUNITY PARTNERS

June 15, 2023
Dorrit Walsh

Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) is a five-year cooperative agreement made possible by the United States Agency for International Development (USAID), with the assistance of the American people, that aims to transform tuberculosis (TB) prevention and care.

Why Hepatitis C Virus Care Remains Inaccessible

May 10, 2023
Dorrit Walsh

This policy brief explores barriers such as the high-burden among marginalized communities, the complicated diagnostic process, and the difficulties of finding the missing millions of people with HCV in most high-burden countries.

TAG Remarks Delivered at Multistakeholder Hearings, May, 2023

May 8, 2023
Dorrit Walsh

TAG prepared these remarks to deliver at multistakeholder hearings on health held on May 8 and 9, 2023, at the United Nations Headquarters in New York City.

Covers of the two nitrosamines publications on this page.

Nitrosamines and TB Medicines Information Note and Patient FAQs

April 19, 2023
Dorrit Walsh

In 2020, health authorities and drug manufacturers identified a type of chemical impurity called nitrosamines in rifampicin and rifapentine, two essential medicines used in the treatment and prevention of TB. TAG and IMPAACT4TB project partners have developed several materials to…

1/4/6×24 Campaign Videos

March 20, 2023
Dorrit Walsh

All people affected by TB have a right to benefit from scientific progress and to access the best-available short-course regimens for TB prevention and treatment. The 1/4/6x24 Campaign demands that countries and other duty bearers take action to implement the…

For World TB Day, TB Advocates Demand Universal Access to Shorter, Safer TB Regimens

March 20, 2023
Dorrit Walsh

On March 24, World Tuberculosis (TB) Day offers an opportunity to take stock of global progress against the deadliest disease in human history. This year, we face a sobering reality: since the start of the COVID-19 pandemic, rates of TB infection and death are higher than they’ve been since the early 2000s, setting back an already woefully inadequate effort to end the disease.

1 / 4 / 6 x 24

March 13, 2023
Dorrit Walsh

Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of 2024.

CROI 2023 Tuberculosis Research Round Up

February 22, 2023
Dorrit Walsh

Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI).